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Biology

Pharmacodynamic phMRI with Joint
Estimation of the Arterial Drug Input Curve
Molly Charney
Mentor: Kevin Black
This study introduces a refinement to a method for quantifying the sensitivity of multiple
brain regions to a drug. Rapid quantitative pharmacodynamic imaging simultaneously
estimates pharmacokinetic (PK) and pharmacodynamic (PD) parameters from a region
of brain through administration of a drug during fMRI BOLD signal collection. Here we
use the fact that the concentration of drug in arterial blood is essentially the same for all
regions of the brain to more tightly estimate the time–concentration curve and hence
reduce unwanted model flexibility in estimating PD parameters. Furthermore, assuming
linear pharmacokinetics, we can appropriately combine responses to the drug across
doses. To test this approach, a dopamine D1-like agonist, SKF38393, was administered
intravenously to baboons (n = 4) during BOLD-sensitive fMRI. Each subject received
four different doses of drug on four different occasions with order randomized. Data
from the hypothalamus, midbrain, and striatum were used to estimate the most likely
time–concentration curve; the 90% confidence interval for this curve was much tighter
than the range of curves when data for each region and dose were considered one at a
time. The most likely time–concentration curve was then used as prior information to
constrain quantification of drug sensitivity (EC50) voxel-wise throughout the brain. The
results support the use of rapid quantitative pharmacological imaging in determining
appropriate and effective dosing for brain disorders such as Parkinson’s disease as well as
for determining arterial drug concentration measurements when this data is not directly
available.
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